Vanda Pharmaceuticals | VNDA - PE Price to Earnings


Vanda Pharmaceuticals reported 16.79 in PE Price to Earnings for its fiscal quarter ending in June of 2023.





Pe Change Date
Acadia Pharmaceuticals 11.33 1.25 Jun/2026
Agios Pharmaceuticals 3.56 0 Mar/2026
Akebia Therapeutics 1.63K 1.6K Dec/2025
Alnylam Pharmaceuticals 75.64 4.4 Jun/2026
Anika Therapeutics 47.54 27.2 Jun/2024
Arrowhead Research 39.19 0 Jun/2026
AstraZeneca 25.34 4.25 Jun/2026
Bristol-Myers Squibb 16.14 7.06 Jun/2026
Eli Lilly 32.9 7.37 Jun/2026
Halozyme Therapeutics 12.51 1.15 Jun/2026
J&J 25.86 3.57 Sep/2026
Lexicon Pharmaceuticals 12.44 4.73 Jun/2021
Ligand Pharmaceuticals 84.31 27.81 Jun/2026
Merck 32.26 15.74 Jun/2026
Moderna 27.22 14.51 Jun/2023
Novartis 21.36 3.57 Mar/2026
Pfizer 11.48 2.16 Jun/2026
PTC Therapeutics 8.76 1.22 Mar/2026
Puma Biotechnology 13.93 44.88 Jun/2024
Sanofi 18.96 7.12 Jun/2026
Takeda 24.4 22.12 Jun/2026
Teva Pharmaceutical Industries 24.6 14.53 Jun/2026
Vanda Pharmaceuticals 16.79 7.07 Jun/2023
Veracyte 42.77 17.88 Jun/2026